Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio Growth (5y) (2016 - 2026)
Arrowhead Pharmaceuticals (ARWR) Interest Coverage Ratio Growth (5y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | Arrowhead Pharmaceuticals | 11.98 Bn | 10.18 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -39.56% |
| Dec 31, 2025 | 34.22% |
| Sep 30, 2025 | -17.32% |
| Jun 30, 2025 | -50.96% |
| Mar 31, 2025 | 132.18% |
| Dec 31, 2024 | -225.85% |
| Sep 30, 2024 | -287.26% |
| Jun 30, 2024 | -130.67% |
| Mar 31, 2024 | -103.07% |
| Dec 31, 2023 | -15.59% |
| Sep 30, 2023 | 24.85% |
| Jun 30, 2023 | -14.73% |
| Mar 31, 2023 | 60.62% |
| Dec 31, 2022 | -21.51% |
| Sep 30, 2022 | -266.06% |
| Jun 30, 2022 | -66.41% |
| Mar 31, 2022 | 48.86% |
| Dec 31, 2021 | 45.43% |
| Sep 30, 2021 | -9.13% |
| Jun 30, 2021 | 50.45% |